Chang T, Ho P
Immune Netw. 2025; 25(1):e8.
PMID: 40078784
PMC: 11896656.
DOI: 10.4110/in.2025.25.e8.
Almawash S
Cancers (Basel). 2025; 17(5).
PMID: 40075727
PMC: 11899125.
DOI: 10.3390/cancers17050880.
Shin S, Branning R, McGinnis M, Shin A, Ho M, Karpyak V
Clin Transl Sci. 2025; 18(3):e70180.
PMID: 40065582
PMC: 11893730.
DOI: 10.1111/cts.70180.
Lee J, Barnett S, Roberts K, Ashwin H, Milross L, Cho J
Nat Commun. 2025; 16(1):1979.
PMID: 40064844
PMC: 11893906.
DOI: 10.1038/s41467-025-56473-x.
Gomez A, Glaria I, Moncayola I, Echeverria I, Arrizabalaga J, Rodriguez-Largo A
Vet Res. 2025; 56(1):51.
PMID: 40055839
PMC: 11889777.
DOI: 10.1186/s13567-025-01475-2.
IFN-α Induces Heterogenous ROS Production in Human β-Cells.
Wagner L, Melnyk O, Turner A, Duffett B, Muralidharan C, Martinez-Irizarry M
bioRxiv. 2025; .
PMID: 40027743
PMC: 11870469.
DOI: 10.1101/2025.02.19.639120.
Reducing batch effects in single cell chromatin accessibility measurements by pooled transposition with MULTI-ATAC.
Conrad D, Phong K, Korotkevich E, McGinnis C, Zhu Q, Chow E
bioRxiv. 2025; .
PMID: 40027737
PMC: 11870453.
DOI: 10.1101/2025.02.14.638353.
Lassa virus protein-protein interactions as mediators of Lassa fever pathogenesis.
Jan S, Phadke K, Lam V, Branda S, Johnson D
Virol J. 2025; 22(1):52.
PMID: 40022100
PMC: 11869472.
DOI: 10.1186/s12985-025-02669-y.
Oncolytic Viruses in Ovarian Cancer: Where Do We Stand? A Narrative Review.
Borella F, Carosso M, Chiparo M, Ferraioli D, Bertero L, Gallio N
Pathogens. 2025; 14(2).
PMID: 40005517
PMC: 11858389.
DOI: 10.3390/pathogens14020140.
The Effects of Fisetin on Gene Expression Profile and Cellular Metabolism in IFN-γ-Stimulated Macrophage Inflammation.
He Z, Pan X, Xie K, Sakao K, Chen J, Komatsu M
Antioxidants (Basel). 2025; 14(2).
PMID: 40002369
PMC: 11852181.
DOI: 10.3390/antiox14020182.
Mechanisms of Resistance to Anti-PD-1 Immunotherapy in Melanoma and Strategies to Overcome It.
Zielinska M, Ciazynska M, Sulejczak D, Rutkowski P, Czarnecka A
Biomolecules. 2025; 15(2).
PMID: 40001572
PMC: 11853485.
DOI: 10.3390/biom15020269.
GDP-bound Rab37 modulates M2-like tumor-associated macrophage polarization by attenuating STAT1 translocation to downregulate the type I IFN pathway.
Hong C, Yang Y, Juan H, Chang C, Wang Y
Br J Cancer. 2025; .
PMID: 39984679
DOI: 10.1038/s41416-025-02955-0.
Candidate approaches for predicting vitiligo recurrence: an effective model and biomarkers.
Liu B, Shen J, Li J, Tian B, Zhou B, Gui J
Front Immunol. 2025; 16:1468665.
PMID: 39981245
PMC: 11839629.
DOI: 10.3389/fimmu.2025.1468665.
The concerted actions of microRNA-29a and interferon-β modulate complete Freund's adjuvant-induced inflammatory pain by regulating the expression of type 1 interferon receptor, interferon-stimulated gene 15, and p-extracellular signal-regulated....
Liu C, Hung K, Li Y, Yi-Kung Huang E, Chu C, Chow L
BJA Open. 2025; 13:100376.
PMID: 39980495
PMC: 11840201.
DOI: 10.1016/j.bjao.2024.100376.
Memory B cells and their transcriptomic profiles associated with belimumab resistance in systemic lupus erythematosus in the maintenance phase.
Iwasaki T, Yoshifuji H, Kitagori K, Sumitomo S, Akizuki S, Nakashima R
Front Immunol. 2025; 16:1506298.
PMID: 39975549
PMC: 11835923.
DOI: 10.3389/fimmu.2025.1506298.
IFN-γ-mediated inhibition of JAK/STAT signaling via nano-scutellarin treatment is an efficient strategy for ameliorating liver fibrosis.
Wang T, Liu B, Huang J, Zhao Q, Shen H, Bi T
J Transl Med. 2025; 23(1):195.
PMID: 39962553
PMC: 11834254.
DOI: 10.1186/s12967-025-06155-5.
Blood-Based Whole-Genome Methylation Analysis of Yili Horses Pre- and Post-Racing.
Wang J, Ren W, Li Z, Ma S, Li L, Wang R
Animals (Basel). 2025; 15(3).
PMID: 39943096
PMC: 11815882.
DOI: 10.3390/ani15030326.
Enhanced conversion of T cells into CAR T cells by modulation of the MAPK/ERK pathway.
Adabi E, Charitidis F, Thalheimer F, Guaza-Lasheras M, Clarke C, Buchholz C
Cell Rep Med. 2025; 6(2):101970.
PMID: 39938523
PMC: 11866553.
DOI: 10.1016/j.xcrm.2025.101970.
Antitumor effects of natural killer cells derived from gene-engineered human-induced pluripotent stem cells on hepatocellular carcinoma.
Nakamura M, Tanaka Y, Hakoda K, Ohira M, Kobayashi T, Kurachi K
Cancer Immunol Immunother. 2025; 74(3):99.
PMID: 39904787
PMC: 11794780.
DOI: 10.1007/s00262-025-03940-5.
Phosphatidylserine (PS)-targeting chimeric Interferon (IFN) fusion proteins for anti-tumor applications.
Gadiyar V, Davra V, Pulica R, Frederick T, Varsanyi C, Aquib A
bioRxiv. 2025; .
PMID: 39896467
PMC: 11785247.
DOI: 10.1101/2025.01.24.634764.